Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a global pharmaceutical company focused on the discovery, development and commercialization of ...
The acquisition represents the seventh exit for Sofinnova Partners in the past three years and is expected to close in the second half of 2026.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results